BIOTON S.A.(PL:BIO)
zł 3.52+0.02 (+1.59%)
PL:BIO
BIOTON S.A. financials statements
zł 3.52
At close:+0.02 (+1.59%)
Want to see PL:BIO full AI Analyst Report?
BIOTON S.A. (BIO) Ratios
0 Followers
BIOTON S.A. Ratios
PL:BIO's free cash flow for Q2 2026 was zł-9.08M. For the 2026 fiscal year, PL:BIO's free cash flow was decreased by zł-6.04M and operating cash flow was zł-3.04M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.41 | 1.08 | 1.01 | 1.09 | 1.05 |
| Quick Ratio | 0.49 | 0.33 | 0.29 | 0.31 | 0.30 |
| Cash Ratio | 0.08 | 0.05 | 0.02 | 0.07 | 0.05 |
| Solvency Ratio | 0.25 | 0.10 | 0.17 | 0.18 | 0.14 |
| Operating Cash Flow Ratio | 0.15 | 0.25 | 0.24 | 0.40 | 0.03 |
| Short-Term Operating Cash Flow Coverage | 0.48 | 0.98 | 0.75 | 1.01 | 0.07 |
| Net Current Asset Value | zł -25.49M | zł -49.59M | zł -49.11M | zł -51.20M | zł -67.72M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.07 | 0.08 | 0.09 | 0.13 |
| Debt-to-Equity Ratio | 0.10 | 0.10 | 0.11 | 0.13 | 0.18 |
| Debt-to-Capital Ratio | 0.09 | 0.09 | 0.10 | 0.11 | 0.15 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.01 | 0.03 |
| Financial Leverage Ratio | 1.29 | 1.34 | 1.36 | 1.34 | 1.43 |
| Debt Service Coverage Ratio | 1.23 | 0.64 | 0.43 | 0.87 | 0.48 |
| Interest Coverage Ratio | 2.19 | -0.70 | 1.81 | 2.71 | 3.16 |
| Debt to Market Cap | 0.12 | 0.15 | 0.18 | 0.21 | 0.26 |
| Interest Debt Per Share | 0.73 | 0.75 | 0.90 | 0.98 | 1.33 |
| Net Debt to EBITDA | 0.95 | 1.52 | 2.07 | 1.15 | 2.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.24% | 31.21% | 40.11% | 41.07% | 46.81% |
| EBIT Margin | 4.53% | -1.79% | -2.05% | 10.36% | 8.25% |
| EBITDA Margin | 18.15% | 15.67% | 17.21% | 25.11% | 27.66% |
| Operating Profit Margin | 4.53% | -2.75% | 8.42% | 9.12% | 8.80% |
| Pretax Profit Margin | 2.77% | -5.72% | 3.98% | 2.12% | 5.11% |
| Net Profit Margin | 1.20% | -7.54% | 1.25% | 0.61% | 1.77% |
| Continuous Operations Profit Margin | 1.20% | -7.54% | 1.25% | 0.61% | 1.77% |
| Net Income Per EBT | 43.33% | 131.80% | 31.45% | 28.70% | 34.59% |
| EBT Per EBIT | 61.13% | 208.09% | 47.30% | 23.29% | 58.09% |
| Return on Assets (ROA) | 0.44% | -1.97% | 0.28% | 0.18% | 0.33% |
| Return on Equity (ROE) | 0.57% | -2.65% | 0.38% | 0.23% | 0.48% |
| Return on Capital Employed (ROCE) | 1.94% | -0.88% | 2.33% | 3.18% | 2.05% |
| Return on Invested Capital (ROIC) | 0.80% | -0.82% | 0.67% | 0.84% | 0.64% |
| Return on Tangible Assets | 0.78% | -3.43% | 0.50% | 0.32% | 0.58% |
| Earnings Yield | 1.02% | -6.31% | 0.73% | 0.49% | 0.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.48 | 7.68 | 4.98 | 8.69 | 4.39 |
| Payables Turnover | 10.38 | 3.77 | 3.29 | 5.59 | 3.52 |
| Inventory Turnover | 1.96 | 1.33 | 0.92 | 1.25 | 0.68 |
| Fixed Asset Turnover | 0.97 | 0.69 | 0.62 | 0.82 | 0.55 |
| Asset Turnover | 0.37 | 0.26 | 0.22 | 0.29 | 0.19 |
| Working Capital Turnover Ratio | 10.65 | 34.50 | 27.55 | 22.56 | 125.46 |
| Cash Conversion Cycle | 200.28 | 224.63 | 357.96 | 268.98 | 513.65 |
| Days of Sales Outstanding | 48.80 | 47.50 | 73.29 | 42.00 | 83.22 |
| Days of Inventory Outstanding | 186.65 | 273.99 | 395.65 | 292.26 | 534.16 |
| Days of Payables Outstanding | 35.17 | 96.86 | 110.97 | 65.27 | 103.73 |
| Operating Cycle | 235.45 | 321.49 | 468.94 | 334.26 | 617.38 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.18 | 0.42 | 0.46 | 0.65 | 0.06 |
| Free Cash Flow Per Share | 0.03 | 0.29 | -0.05 | 0.31 | -0.09 |
| Dividend Paid and CapEx Coverage Ratio | 1.17 | 3.13 | 0.90 | 1.90 | 0.43 |
| Capital Expenditure Coverage Ratio | 1.17 | 3.13 | 0.90 | 1.90 | 0.43 |
| Operating Cash Flow Coverage Ratio | 0.27 | 0.64 | 0.58 | 0.73 | 0.05 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.17 | 0.22 | 0.24 | 0.03 |
| Free Cash Flow Yield | 0.69% | 9.96% | -1.46% | 9.16% | -2.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 97.72 | -16.06 | 136.25 | 203.63 | 124.68 |
| Price-to-Sales (P/S) Ratio | 1.17 | 1.19 | 1.71 | 1.24 | 2.20 |
| Price-to-Book (P/B) Ratio | 0.56 | 0.42 | 0.51 | 0.48 | 0.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 145.62 | 10.04 | -68.26 | 10.92 | -48.76 |
| Price-to-Operating Cash Flow Ratio | 21.60 | 6.83 | 7.82 | 5.16 | 65.07 |
| Price-to-Earnings Growth (PEG) Ratio | -0.80 | 0.02 | 2.25 | -4.00 | -1.36 |
| Enterprise Value Multiple | 7.42 | 9.14 | 11.99 | 6.09 | 10.21 |
| Enterprise Value | 380.32M | 297.75M | 374.78M | 356.42M | 460.56M |
| EV to EBITDA | 7.42 | 9.14 | 11.99 | 6.09 | 10.21 |
| EV to Sales | 1.35 | 1.43 | 2.06 | 1.53 | 2.82 |
| EV to Free Cash Flow | 167.10 | 12.05 | -82.53 | 13.45 | -62.49 |
| EV to Operating Cash Flow | 24.79 | 8.20 | 9.46 | 6.36 | 83.40 |
| Tangible Book Value Per Share | 3.11 | 2.94 | 2.76 | 2.77 | 2.97 |
| Shareholders’ Equity Per Share | 6.92 | 6.88 | 7.06 | 7.06 | 7.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.57 | -0.32 | 0.69 | 0.71 | 0.65 |
| Revenue Per Share | 3.29 | 2.42 | 2.12 | 2.72 | 1.90 |
| Net Income Per Share | 0.04 | -0.18 | 0.03 | 0.02 | 0.03 |
| Tax Burden | 0.43 | 1.32 | 0.31 | 0.29 | 0.35 |
| Interest Burden | 0.61 | 3.19 | -1.94 | 0.21 | 0.62 |
| Research & Development to Revenue | 0.01 | 0.02 | 0.03 | 0.02 | 0.03 |
| SG&A to Revenue | 0.26 | 0.32 | 0.17 | 0.13 | 0.17 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 4.52 | -2.32 | 17.42 | 39.47 | 1.92 |
Currency in PLN
